Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
+22.2M
-
Total reported value, excl. options
-
$604M
-
Value change
-
+$546M
-
Number of buys
-
52
-
Price
-
$24.67
Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q3 2020
53 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2020.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 38M outstanding shares and own 64.6% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.42M shares), BOXER CAPITAL, LLC (4.35M shares), MPM ASSET MANAGEMENT LLC (3.71M shares), MPM ONCOLOGY IMPACT MANAGEMENT LP (2.36M shares), Artal Group S.A. (1.09M shares), JANUS HENDERSON GROUP PLC (1M shares), RTW INVESTMENTS, LP (903K shares), CITADEL ADVISORS LLC (898K shares), ALLIANCEBERNSTEIN L.P. (768K shares), and BlackRock Inc. (662K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.